Analysis of helicobacter pylori caga promoter elements required for salt-induced upregulation of caga expression

Infection and Immunity

Volumn 80, Issue 9, 2012, Pages 3094-3106

  Loh, John T ^a   Friedman, David B ^a   Piazuelo, M Blanca ^a   Bravo, Luis E ^b   Wilson, Keith T ^a,c   Peek, Richard M ^a   Correa, Pelayo ^a   Covera, Timothy L ^a,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSIDAD DEL VALLE   (Colombia)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN; SODIUM CHLORIDE;

ARTICLE; CANCER RISK; COLOMBIA; CONTROLLED STUDY; DIET; DOWN REGULATION; GENE DELETION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEOMICS; STOMACH CANCER; UPREGULATION;

EID: 84867606934     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00232-12     Document Type: Article

References (43)

1. Amieva MR, El-Omar EM. 2008. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 134:306-323.
2. Atherton JC, Blaser MJ. 2009. Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J. Clin. Invest. 119:2475-2487.
3. Backert S, Tegtmeyer N, Selbach M. 2010. The versatility of Helicobacter pylori CagA effector protein functions: the master key hypothesis. Helicobacter 15:163-176.
4. Basso D, et al. 2008. Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 135:91-99.
5. Bellair M, Withey JH. 2008. Flexibility of Vibrio cholerae ToxT in transcription activation of genes having altered promoter spacing. J. Bacteriol. 190:7925-7931.
6. Blaser MJ. 2005. The biology of cag in the Helicobacter pylori-human interaction. Gastroenterology 128:1512-1515.
7. Blaser MJ, et al. 1995. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 55:2111-2115.
8. Chen VW, et al. 1990. Risk factors of gastric precancerous lesions in a high-risk Colombian population. II. Nitrate and nitrite. Nutr. Cancer 13: 67-72.
9. Cover TL, Blaser MJ. 2009. Helicobacter pylori in health and disease. Gastroenterology 136:1863-1873.
10. de Sablet T, et al. 2011. Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer risk. Gut 60:1189-1195.
11. Figueiredo C, et al. 2002. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J. Natl. Cancer Inst. 94:1680-1687.
12. Forsyth MH, Cover TL. 1999. Mutational analysis of the vacA promoter provides insight into gene transcription in Helicobacter pylori. J. Bacteriol. 181:2261-2266.
13. Gancz H, Jones KR, Merrell DS. 2008. Sodium chloride affects Helicobacter pylori growth and gene expression. J. Bacteriol. 190:4100-4105.
14. Gancz H, Merrell DS. 2011. The Helicobacter pylori ferric uptake regulator (Fur) is essential for growth under sodium chloride stress. J. Microbiol. 49:294-298.
15. Goetze O, et al. 2007. The effect of macronutrients on gastric volume responses and gastric emptying in humans: a magnetic resonance imaging study. Am. J. Physiol. Gastrointest. Liver Physiol. 292:G11-G17.
16. Hatakeyama M. 2004. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat. Rev. Cancer 4:688-694.
17. Hidalgo E, Demple B. 1997. Spacing of promoter elements regulates the basal expression of the soxS gene and converts SoxR from a transcriptional activator into a repressor. EMBO J. 16:1056-1065.
18. Higashi H, et al. 2005. EPIYA motif is a membrane-targeting signal of Helicobacter pylori virulence factor CagA in mammalian cells. J. Biol. Chem. 280:23130-23137.
19. Howson CP, Hiyama T, Wynder EL. 1986. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol. Rev. 8:1-27.
20. Huang JQ, Zheng GF, Sumanac K, Irvine EJ, Hunt RH. 2003. Metaanalysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology 125:1636-1644.
21. Jones KR, Whitmire JM, Merrell DS. 2010. A tale of two toxins: Helicobacter pylori CagA and VacA modulate host pathways that impact disease. Front. Microbiol. 1:115. doi:10.3389/fmicb.2010.00115.
22. Loh JT, Gupta SS, Friedman DB, Krezel AM, Cover TL. 2010. Analysis of protein expression regulated by the Helicobacter pylori ArsRS twocomponent signal transduction system. J. Bacteriol. 192:2034-2043.
23. Loh JT, et al. 2011. Analysis of cagA in Helicobacter pylori strains from Colombian populations with contrasting gastric cancer risk reveals a biomarker for disease severity. Cancer Epidemiol. Biomarkers Prev. 20:2237-2249.
24. Loh JT, Torres VJ, Algood HM, McClain MS, Cover TL. 2008. Helicobacter pylori HopQ outer membrane protein attenuates bacterial adherence to gastric epithelial cells. FEMS Microbiol. Lett. 289:53-58.
25. Loh JT, Torres VJ, Cover TL. 2007. Regulation of Helicobacter pylori cagA expression in response to salt. Cancer Res. 67:4709-4715.
26. Naito M, et al. 2006. Influence of EPIYA-repeat polymorphism on the phosphorylation-dependent biological activity of Helicobacter pylori CagA. Gastroenterology 130:1181-1190.
27. Ni X, Westpheling J. 1997. Direct repeat sequences in the Streptomyces chitinase-63 promoter direct both glucose repression and chitin induction. Proc. Natl. Acad. Sci. U. S. A. 94:13116-13121.
28. Nozaki K, et al. 2002. Synergistic promoting effects of Helicobacter pylori infection and high-salt diet on gastric carcinogenesis in Mongolian gerbils. Jpn. J. Cancer Res. 93:1083-1089.
29. Parsonnet J, Friedman GD, Orentreich N, Vogelman H. 1997. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 40:297-301.
30. Plummer M, et al. 2007. Helicobacter pylori cytotoxin-associated genotype gastric precancerous lesions. J. Natl. Cancer Inst. 99:1328-1334.
31. Polk DB, Peek RM, Jr. 2010. Helicobacter pylori: gastric cancer and beyond. Nat. Rev. Cancer 10:403-414.
32. Shaffer CL, et al. 2011. Helicobacter pylori exploits a unique repertoire of type IV secretion system components for pilus assembly at the bacteriahost cell interface. PLoS Pathog. 7:e1002237. doi:10.1371/journal.ppat.1002237.
33. Shaik MM, Cendron L, Percudani R, Zanotti G. 2011. The structure of Helicobacter pylori HP0310 reveals an atypical peptidoglycan deacetylase. PLoS One 6:e19207. doi:10.1371/journal.pone.0019207.
34. Spohn G, Beier D, Rappuoli R, Scarlato V. 1997. Transcriptional analysis of the divergent cagAB genes encoded by the pathogenicity island of Helicobacter pylori. Mol. Microbiol. 26:361-372.
35. Suerbaum S, Michetti P. 2002. Helicobacter pylori infection. N. Engl. J. Med. 347:1175-1186.
36. Tatematsu M, Nozaki K, Tsukamoto T. 2003. Helicobacter pylori infection and gastric carcinogenesis in animal models. Gastric Cancer. 6:1-7.
37. Tegtmeyer N, Wessler S, Backert S. 2011. Role of the cag-pathogenicity island encoded type IV secretion system in Helicobacter pylori pathogenesis. FEBS J. 278:1190-1202.
38. Tsugane S. 2005. Salt, salted food intake, and risk of gastric cancer: epidemiologic evidence. Cancer Sci. 96:1-6.
39. 80 family of promoter signals. J. Mol. Biol. 297:335-353.
40. Varma A, Young KD. 2004. FtsZ collaborates with penicillin binding proteins to generate bacterial cell shape in Escherichia coli. J. Bacteriol. 186:6768-6774.
41. Wang G, et al. 2010. Peptidoglycan deacetylation in Helicobacter pylori contributes to bacterial survival by mitigating host immune responses. Infect. Immun. 78:4660-4666.
42. Withey JH, DiRita VJ. 2006. The toxbox: specific DNA sequence requirements for activation of Vibrio cholerae virulence genes by ToxT. Mol. Microbiol. 59:1779-1789.
43. You WC, et al. 1988. Diet and high risk of stomach cancer in Shandong, China. Cancer Res. 48:3518-3523.